BIOC Articles, Biocept Inc.
home / stock / bioc / bioc articles
-
Over the past twenty days of trading, Biocept Inc. (NASDAQ: BIOC), from October 15, 2019 to April 13, 2020 there is a potential Short Squeeze about...
News, Short Squeeze, Breakout and More Instantly...
-
Biocept, Inc . (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the appointment of RSM US LLP (“RSM”) as its independent registered public accounting firm effective June 24, 2022. RSM was recently ranked the fifth larg...
-
Biocept’s CNSide™ assay provides a highly sensitive method to assess and quantify tumor cell burden in leptomeningeal metastasis (LM) of the central nervous system Assay results will be used to evaluate response to treatment and treatment efficacy for patients enro...
-
Biocept, Inc. (Nasdaq: BIOC) management will hold a conference call today, June 7, 2022, beginning at 4:00 p.m. Eastern time to discuss its re-focused and rationalized business strategy and to answer questions. Participants can pre-register for the conference call here . Cal...